Suppr超能文献

体外和分子对接评估从安息香科(Combretaceae)中提取的化合物的抗胆碱酯酶和抗糖尿病作用。

In Vitro and Molecular Docking Evaluation of the Anticholinesterase and Antidiabetic Effects of Compounds from Guill. & Perr. (Combretaceae).

机构信息

Department of Chemistry, Faculty of Sciences, University of Ngaoundere, Ngaoundere P.O. Box 454, Cameroon.

Department of Chemical Engineering, School of Chemical Engineering and Mineral Industries, University of Ngaoundere, Ngaoundere P.O. Box 454, Cameroon.

出版信息

Molecules. 2024 May 23;29(11):2456. doi: 10.3390/molecules29112456.

Abstract

Alzheimer's disease (AD) and diabetes are non-communicable diseases with global impacts. Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are suitable therapies for AD, while α-amylase and α-glucosidase inhibitors are employed as antidiabetic agents. Compounds were isolated from the medicinal plant and evaluated for their AChE, BChE, α-amylase, and α-glucosidase inhibitions. From H and C NMR data, the compounds were identified as 3,3'-di-O-methyl ellagic acid (), 3,3',4'-tri-O-methyl ellagic acid-4-O-β-D-xylopyranoside (), 3,3',4'-tri-O-methyl ellagic acid-4-O-β-D-glucopyranoside (), 3,3'-di-O-methyl ellagic acid-4-O-β-D-glucopyranoside (), myricetin-3-O-rhamnoside (), shikimic acid (), arjungenin (), terminolic acid (), 24-deoxysericoside (), arjunglucoside I (), and chebuloside II (). The derivatives of ellagic acid (-) showed moderate to good inhibition of cholinesterases, with the most potent being 3,3'-di-O-methyl ellagic acid, with IC values of 46.77 ± 0.90 µg/mL and 50.48 ± 1.10 µg/mL against AChE and BChE, respectively. The compounds exhibited potential inhibition of α-amylase and α-glucosidase, especially the phenolic compounds (-). Myricetin-3-O-rhamnoside had the highest α-amylase inhibition with an IC value of 65.17 ± 0.43 µg/mL compared to acarbose with an IC value of 32.25 ± 0.36 µg/mL. Two compounds, 3,3'-di-O-methyl ellagic acid (IC = 74.18 ± 0.29 µg/mL) and myricetin-3-O-rhamnoside (IC = 69.02 ± 0.65 µg/mL), were more active than the standard acarbose (IC = 87.70 ± 0.68 µg/mL) in the α-glucosidase assay. For α-glucosidase and α-amylase, the molecular docking results for reveal that these compounds may fit well into the binding sites of the target enzymes, establishing stable complexes with negative binding energies in the range of -4.03 to -10.20 kcalmol. Though not all the compounds showed binding affinities with cholinesterases, some had negative binding energies, indicating that the inhibition was thermodynamically favorable.

摘要

阿尔茨海默病(AD)和糖尿病是具有全球影响的非传染性疾病。乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)抑制剂是 AD 的合适治疗方法,而α-淀粉酶和α-葡萄糖苷酶抑制剂则用作抗糖尿病药物。从药用植物中分离出化合物,并评估其对 AChE、BChE、α-淀粉酶和α-葡萄糖苷酶的抑制作用。根据 1H 和 13C NMR 数据,这些化合物被鉴定为 3,3'-二-O-甲基鞣花酸()、3,3',4'-三-O-甲基鞣花酸-4-O-β-D-吡喃木糖苷()、3,3',4'-三-O-甲基鞣花酸-4-O-β-D-葡萄糖苷()、3,3'-二-O-甲基鞣花酸-4-O-β-D-吡喃葡萄糖苷()、杨梅素-3-O-鼠李糖苷()、莽草酸()、阿江榄仁苷()、特米灵酸()、24-脱氧赤藓醇()、阿江苷 I()和诃子次酸 II()。鞣花酸衍生物()对胆碱酯酶具有中等至良好的抑制作用,其中最有效的是 3,3'-二-O-甲基鞣花酸,对 AChE 和 BChE 的 IC 值分别为 46.77±0.90 µg/mL 和 50.48±1.10 µg/mL。这些化合物对α-淀粉酶和α-葡萄糖苷酶具有潜在的抑制作用,特别是酚类化合物()。杨梅素-3-O-鼠李糖苷对α-淀粉酶的抑制作用最强,IC 值为 65.17±0.43 µg/mL,而阿卡波糖的 IC 值为 32.25±0.36 µg/mL。两种化合物,3,3'-二-O-甲基鞣花酸(IC = 74.18±0.29 µg/mL)和杨梅素-3-O-鼠李糖苷(IC = 69.02±0.65 µg/mL),在α-葡萄糖苷酶测定中比标准阿卡波糖(IC = 87.70±0.68 µg/mL)更活跃。对于α-葡萄糖苷酶和α-淀粉酶,显示这些化合物可能与靶酶的结合位点很好地契合,形成结合能在-4.03 至-10.20 kcalmol 范围内的稳定复合物。虽然并非所有化合物都与胆碱酯酶具有结合亲和力,但有些化合物具有负结合能,表明抑制作用在热力学上是有利的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e7/11174011/f3f50f438f3b/molecules-29-02456-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验